01 1Sri Krishna Pharmaceuticals
01 1FUROSEMIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-11
Pay. Date : 2013-06-28
DMF Number : 23396
Submission : 2009-12-22
Status : Active
Type : II
20
Sri Krishna Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FUROSEMIDE USP, with a corresponding US DMF Number 23396.
Remarkably, this DMF maintains an Active status since its submission on December 22, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 11, 2013, and payment made on June 28, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
